Orilissa (elagolix) is the first FDA-approved oral treatment for moderate to severe endometriosis pain in more than a decade.
CHICAGO – The findings suggest that lifelong estrogen exposure may exert a neuroprotective effect in women.
Most evidence supporting this hypothesis comes from animal studies.
TORONTO – As pregnant women use more opioids, NAS rates are soaring; they rose from 1.2/1,000 U.S. hospital births in 2000 to 8/1,000 in 2014.
Can cell-free DNA testing reduce unnecessary use of anti-D immunoglobulin in RhD-negative women and still prevent harm to their RhD-positive...
Outcomes Research in Review
Infertility and adverse pregnancy outcomes in HCV-infected women appear associated with increased ovarian senescence.
The vaccine may offer greater flexibility beyond the early portion of the trimester.